BioLife Solutions Statistics
Share Statistics
BioLife Solutions has 47.56M
shares outstanding. The number of shares has increased by 2.02%
in one year.
| Shares Outstanding | 47.56M |
| Shares Change (YoY) | 2.02% |
| Shares Change (QoQ) | 1.32% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,125 |
| FTD / Avg. Volume | 0.75% |
Short Selling Information
The latest short interest is 3.94M, so 8.29% of the outstanding
shares have been sold short.
| Short Interest | 3.94M |
| Short % of Shares Out | 8.29% |
| Short % of Float | 12.24% |
| Short Ratio (days to cover) | 7.64 |
Valuation Ratios
The PE ratio is -59.25 and the forward
PE ratio is 247.11.
BioLife Solutions's PEG ratio is
0.83.
| PE Ratio | -59.25 |
| Forward PE | 247.11 |
| PS Ratio | 14.54 |
| Forward PS | 5.2 |
| PB Ratio | 3.43 |
| P/FCF Ratio | 229.8 |
| PEG Ratio | 0.83 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for BioLife Solutions.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.54,
with a Debt / Equity ratio of 0.09.
| Current Ratio | 4.54 |
| Quick Ratio | 3.66 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 19.7 |
| Debt / FCF | 5.8 |
| Interest Coverage | -9.92 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $517,320.75 |
| Profits Per Employee | $-126,943.4 |
| Employee Count | 159 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.84 |
Taxes
| Income Tax | -38K |
| Effective Tax Rate | 0.33% |
Stock Price Statistics
The stock price has increased by 3.57% in the
last 52 weeks. The beta is 2.01, so BioLife Solutions's
price volatility has been higher than the market average.
| Beta | 2.01 |
| 52-Week Price Change | 3.57% |
| 50-Day Moving Average | 23.3 |
| 200-Day Moving Average | 24.92 |
| Relative Strength Index (RSI) | 46.82 |
| Average Volume (20 Days) | 547,095 |
Income Statement
In the last 12 months, BioLife Solutions had revenue of 82.25M
and earned -20.18M
in profits. Earnings per share was -0.44.
| Revenue | 82.25M |
| Gross Profit | 57.75M |
| Operating Income | -7.13M |
| Net Income | -20.18M |
| EBITDA | 1.53M |
| EBIT | -7.13M |
| Earnings Per Share (EPS) | -0.44 |
Full Income StatementBalance Sheet
The company has 95.39M in cash and 30.17M in
debt, giving a net cash position of 65.21M.
| Cash & Cash Equivalents | 95.39M |
| Total Debt | 30.17M |
| Net Cash | 65.21M |
| Retained Earnings | -335.1M |
| Total Assets | 395.14M |
| Working Capital | 103.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 8.43M
and capital expenditures -3.23M, giving a free cash flow of 5.2M.
| Operating Cash Flow | 8.43M |
| Capital Expenditures | -3.23M |
| Free Cash Flow | 5.2M |
| FCF Per Share | 0.11 |
Full Cash Flow StatementMargins
Gross margin is 70.21%, with operating and profit margins of -8.67% and -24.54%.
| Gross Margin | 70.21% |
| Operating Margin | -8.67% |
| Pretax Margin | -13.89% |
| Profit Margin | -24.54% |
| EBITDA Margin | 1.86% |
| EBIT Margin | -8.67% |
| FCF Margin | 6.33% |
